We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
International Paper
IP
$21.6B
| $31.3M | 0.05% |
717,554
+25,194
| +4% | +$1.06M |
|
327
Teradyne
TER
$57.6B
| $31.1M | 0.05% |
455,935
+3,368
| +0.7% | +$214K |
|
|
KSU
328
DELISTED
Kansas City Southern
KSU
| $31M | 0.05% |
202,610
+10,511
| +5% | +$1.54M |
|
329
Celanese
CE
$4.9B
| $30.9M | 0.05% |
250,593
+12,755
| +5% | +$1.57M |
|
|
HOLX
330
DELISTED
Hologic
HOLX
| $30.7M | 0.05% |
587,294
+33,082
| +6% | +$1.65M |
|
331
Lennar Class A
LEN
$19.8B
| $30.6M | 0.05% |
566,721
+33,944
| +6% | +$1.94M |
|
332
Equifax
EFX
$20.3B
| $30.5M | 0.05% |
217,424
+8,931
| +4% | +$1.24M |
|
333
Expeditors International
EXPD
$22B
| $30.4M | 0.05% |
389,581
+9,225
| +2% | +$691K |
|
|
FRC
334
DELISTED
First Republic Bank
FRC
| $30.2M | 0.05% |
257,549
+8,893
| +4% | +$961K |
|
335
Nucor
NUE
$58.6B
| $30.1M | 0.05% |
535,605
+22,369
| +4% | +$1.22M |
|
336
NVR
NVR
$16.5B
| $30.1M | 0.05% |
7,904
+1,095
| +16% | +$4.05M |
|
337
W.W. Grainger
GWW
$65.3B
| $29.9M | 0.05% |
88,312
+1,249
| +1% | +$396K |
|
|
K
338
DELISTED
Kellanova
K
| $29.9M | 0.05% |
460,353
+26,228
| +6% | +$1.59M |
|
339
Factset
FDS
$9.36B
| $29.9M | 0.05% |
111,318
-6,657
| -6% | -$1.71M |
|
|
MXIM
340
DELISTED
Maxim Integrated Products
MXIM
| $29.6M | 0.05% |
481,824
+19,145
| +4% | +$1.11M |
|
341
Mid-America Apartment Communities
MAA
$15.4B
| $29.5M | 0.05% |
223,895
+16,804
| +8% | +$2.25M |
|
342
iShares Core S&P 500 ETF
IVV
$878B
| $29.4M | 0.05% |
91,101
+14,489
| +19% | +$4.48M |
|
343
Martin Marietta Materials
MLM
$31.5B
| $29.3M | 0.05% |
104,764
+3,317
| +3% | +$885K |
|
344
MGM Resorts International
MGM
$11.4B
| $29.2M | 0.05% |
878,595
+36,080
| +4% | +$1.1M |
|
|
VAR
345
DELISTED
Varian Medical Systems, Inc.
VAR
| $29.2M | 0.05% |
205,613
-9,884
| -5% | -$1.26M |
|
346
Genuine Parts
GPC
$17.1B
| $29M | 0.05% |
273,196
+1,667
| +0.6% | +$171K |
|
347
Darden Restaurants
DRI
$23.3B
| $28.9M | 0.05% |
265,010
+3,900
| +1% | +$443K |
|
|
TIF
348
DELISTED
Tiffany & Co.
TIF
| $28.9M | 0.05% |
216,076
+12,771
| +6% | +$1.51M |
|
349
Xylem
XYL
$27.3B
| $28.8M | 0.05% |
365,658
+10,445
| +3% | +$813K |
|
350
Cardinal Health
CAH
$53.9B
| $28.8M | 0.05% |
568,885
+26,800
| +5% | +$1.38M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.